Mid term results after bone marrow laser revascularization for treating refractory angina

<p>Abstract</p> <p>Background</p> <p>To evaluate the midterm results of patients with angina and diffuse coronary artery disease treated with transmyocardial revascularization in combination with autologous stem cell therapy.</p> <p>Methods</p> <p&g...

Full description

Bibliographic Details
Main Authors: Caballero Paloma, Olivera MariaJose, Aguado Beatriz, Alegre Adrian, Álvarez Pablo, Allen Keith B, Reyes Guillermo, Rodríguez JoseLuis, Duarte Juan
Format: Article
Language:English
Published: BMC 2010-09-01
Series:BMC Cardiovascular Disorders
Online Access:http://www.biomedcentral.com/1471-2261/10/42
_version_ 1811282444821725184
author Caballero Paloma
Olivera MariaJose
Aguado Beatriz
Alegre Adrian
Álvarez Pablo
Allen Keith B
Reyes Guillermo
Rodríguez JoseLuis
Duarte Juan
author_facet Caballero Paloma
Olivera MariaJose
Aguado Beatriz
Alegre Adrian
Álvarez Pablo
Allen Keith B
Reyes Guillermo
Rodríguez JoseLuis
Duarte Juan
author_sort Caballero Paloma
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>To evaluate the midterm results of patients with angina and diffuse coronary artery disease treated with transmyocardial revascularization in combination with autologous stem cell therapy.</p> <p>Methods</p> <p>Nineteen patients with diffuse coronary artery disease and medically refractory class III/IV angina were evaluated between June 2007 and December 2009 for sole therapy TMR combined with intramyocardial injection of concentrated stem cells. At the time of surgery, autologous bone marrow (120cc) was aspirated from the iliac crest. A cardiac MRI and an isotopic test were performed before and after the procedure. Follow-up was performed by personal interview.</p> <p>Results</p> <p>There were no perioperative adverse events including no arrhythmias. Mean number of laser channels was 20 and the mean total number of intramyocardially injected cells per milliliter were: total mononuclear cells(83.6 × 10<sup>6</sup>), CD34+ cells(0.6 × 10<sup>6</sup>), and CD133+ cells(0.34 × 10<sup>6</sup>). At 12 months mean follow-up average angina class was significantly improved (3.4 ± 0.5 vs 1.4 ± 0.6; p = 0.004). In addition, monthly cardiovascular medication usage was significantly decreased (348 ± 118 vs. 201 ± 92; p = 0.001). At six months follow up there was a reduction in the number of cardiac hospital readmissions (2.9 ± 2.3 vs. 0.5 ± 0.8; p < 0.001). MRI showed no alterations regarding LV volumes and a 3% improvement regarding ejection fraction.</p> <p>Conclusions</p> <p>The stem cell isolator efficiently concentrated autologous bone marrow derived stem cells while the TMR/stem cell combination delivery device worked uneventfully. An improvement in clinical status was noticed in the midterm follow-up. Images test showed no morphological alterations in the left ventricle after the procedure.</p>
first_indexed 2024-04-13T01:52:48Z
format Article
id doaj.art-5e13a835163b40c6970935ce864bb238
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-04-13T01:52:48Z
publishDate 2010-09-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-5e13a835163b40c6970935ce864bb2382022-12-22T03:07:50ZengBMCBMC Cardiovascular Disorders1471-22612010-09-011014210.1186/1471-2261-10-42Mid term results after bone marrow laser revascularization for treating refractory anginaCaballero PalomaOlivera MariaJoseAguado BeatrizAlegre AdrianÁlvarez PabloAllen Keith BReyes GuillermoRodríguez JoseLuisDuarte Juan<p>Abstract</p> <p>Background</p> <p>To evaluate the midterm results of patients with angina and diffuse coronary artery disease treated with transmyocardial revascularization in combination with autologous stem cell therapy.</p> <p>Methods</p> <p>Nineteen patients with diffuse coronary artery disease and medically refractory class III/IV angina were evaluated between June 2007 and December 2009 for sole therapy TMR combined with intramyocardial injection of concentrated stem cells. At the time of surgery, autologous bone marrow (120cc) was aspirated from the iliac crest. A cardiac MRI and an isotopic test were performed before and after the procedure. Follow-up was performed by personal interview.</p> <p>Results</p> <p>There were no perioperative adverse events including no arrhythmias. Mean number of laser channels was 20 and the mean total number of intramyocardially injected cells per milliliter were: total mononuclear cells(83.6 × 10<sup>6</sup>), CD34+ cells(0.6 × 10<sup>6</sup>), and CD133+ cells(0.34 × 10<sup>6</sup>). At 12 months mean follow-up average angina class was significantly improved (3.4 ± 0.5 vs 1.4 ± 0.6; p = 0.004). In addition, monthly cardiovascular medication usage was significantly decreased (348 ± 118 vs. 201 ± 92; p = 0.001). At six months follow up there was a reduction in the number of cardiac hospital readmissions (2.9 ± 2.3 vs. 0.5 ± 0.8; p < 0.001). MRI showed no alterations regarding LV volumes and a 3% improvement regarding ejection fraction.</p> <p>Conclusions</p> <p>The stem cell isolator efficiently concentrated autologous bone marrow derived stem cells while the TMR/stem cell combination delivery device worked uneventfully. An improvement in clinical status was noticed in the midterm follow-up. Images test showed no morphological alterations in the left ventricle after the procedure.</p>http://www.biomedcentral.com/1471-2261/10/42
spellingShingle Caballero Paloma
Olivera MariaJose
Aguado Beatriz
Alegre Adrian
Álvarez Pablo
Allen Keith B
Reyes Guillermo
Rodríguez JoseLuis
Duarte Juan
Mid term results after bone marrow laser revascularization for treating refractory angina
BMC Cardiovascular Disorders
title Mid term results after bone marrow laser revascularization for treating refractory angina
title_full Mid term results after bone marrow laser revascularization for treating refractory angina
title_fullStr Mid term results after bone marrow laser revascularization for treating refractory angina
title_full_unstemmed Mid term results after bone marrow laser revascularization for treating refractory angina
title_short Mid term results after bone marrow laser revascularization for treating refractory angina
title_sort mid term results after bone marrow laser revascularization for treating refractory angina
url http://www.biomedcentral.com/1471-2261/10/42
work_keys_str_mv AT caballeropaloma midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT oliveramariajose midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT aguadobeatriz midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT alegreadrian midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT alvarezpablo midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT allenkeithb midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT reyesguillermo midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT rodriguezjoseluis midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina
AT duartejuan midtermresultsafterbonemarrowlaserrevascularizationfortreatingrefractoryangina